Coverage and reimbursement decisions are hardly predictable or consistent within and across US payers. Payers are in the position of determining which drugs to pay for, for whom, and at what level to ...

Institutional investors face complex decisions—where to allocate capital, which managers to trust, how to weather volatility. These choices can’t rely on instinct alone. They require data, structure, ...

Forbes contributors publish independent expert analyses and insights. Some decisions are made easily and quickly. They just feel right. Others, though, lead to laborious analysis, long consideration, ...

The production cost and the need to pursue quality control initiatives are seen as the major triggers of a make-or-buy decision analysis in procurement. SUPPLY chain management is an area where the ...